Trials / Completed
CompletedNCT06895356
A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants
A Phase 1, Two Part, Randomized, Single and Multiple Dose Crossover Study to Assess the Relative Bioavailability Between Tavapadon Clinical and Commercial Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the relative bioavailability of two different Oral formulations of tavapadon in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tavapadon | Oral: Tablet |
Timeline
- Start date
- 2025-03-26
- Primary completion
- 2025-06-16
- Completion
- 2025-06-16
- First posted
- 2025-03-26
- Last updated
- 2025-06-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06895356. Inclusion in this directory is not an endorsement.